Literature DB >> 26844847

Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer.

Shiyong Zhao1, Xuedong Chen2, Ming Wan3, Xingming Jiang1, Chunlong Li1, Yunfu Cui1, Pengcheng Kang1.   

Abstract

Pancreatic cancer is notoriously becoming one of the most devastating human cancers leading to death. However, clinical challenges still remain in diagnosis and treatment of this ticklish cancer. In the present study, the authors identified a new gene, Tectonic 1 (TCTN1), as a key regulator of cell proliferation in pancreatic cancer. Lentivirus-mediated short hairpin RNA (shRNA) was employed to knock down endogenous TCTN1 expression in PANC-1 pancreatic cancer cells. Knockdown of TCTN1 expression potently inhibited cell viability and proliferation, as determined by MTT and colony formation assays. Western blotting analysis also showed that knockdown of TCTN1 suppressed the expression of cdc2, while it induced that of p21 and p27. Flow cytometry analysis showed that depletion of TCTN1 in PANC-1 cells led to cell cycle arrest in the G2/M phase as well as apoptosis. Besides, depletion of TCTN1 led to the increase of Bax and cleavage of PARP-1, but the decrease of bcl2 by western blotting. The data indicate that TCTN1 is indispensable for pancreatic cancer cell proliferation, which provides a novel alternative to targeted therapy of pancreatic cancer and deserves further investigation.

Entities:  

Keywords:  cell cycle; pancreatic cancer; proliferation; shRNA; tectonic 1

Mesh:

Substances:

Year:  2016        PMID: 26844847     DOI: 10.1089/cbr.2014.1778

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  7 in total

1.  Retraction of: Ribosomal Protein S15A Augments Human Osteosarcoma Cell Proliferation In Vitro (doi: 10.1089/cbr.2014.1698).

Authors: 
Journal:  Cancer Biother Radiopharm       Date:  2021-09-30       Impact factor: 3.099

2.  Retraction of: Lentivirus-Mediated Knockdown of Myosin VI Inhibits Cell Proliferation of Breast Cancer Cell (doi: 10.1089/cbr.2014.1759).

Authors: 
Journal:  Cancer Biother Radiopharm       Date:  2021-09-30       Impact factor: 3.099

3.  Knockdown of TCTN1 Strongly Decreases Growth of Human Colon Cancer Cells.

Authors:  Xiaoyu Dai; Mingjun Dong; Hua Yu; Yangyang Xie; Yongming Yu; Yisheng Cao; Zhenfang Kong; Baofeng Zhou; Yidong Xu; Tong Yang; Keqiang Li
Journal:  Med Sci Monit       Date:  2017-01-26

4.  TCTN2: a novel tumor marker with oncogenic properties.

Authors:  David Cano-Rodriguez; Susanna Campagnoli; Alberto Grandi; Matteo Parri; Elisa De Camilli; Chaojun Song; Boquan Jin; Aurelien Lacombe; Andrea Pierleoni; Mauro Bombaci; Chiara Cordiglieri; Marcel Hj Ruiters; Giuseppe Viale; Luigi Terracciano; Paolo Sarmientos; Sergio Abrignani; Guido Grandi; Piero Pileri; Marianne G Rots; Renata Grifantini
Journal:  Oncotarget       Date:  2017-08-24

5.  Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer.

Authors:  Peipei Xu; Xiaotian Xia; Zhili Yang; Yuan Tian; Jianzhong Di; Minggao Guo
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

6.  MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma.

Authors:  Lixun Chai; Gengpu Yang
Journal:  Cell Mol Biol Lett       Date:  2019-06-28       Impact factor: 5.787

7.  MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1.

Authors:  Wei Liu; Xiuwei Wan; Zongyun Mu; Fei Li; Lei Wang; Jing Zhao; Xiaori Huang
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.